Literature DB >> 35769808

Merlin-Deficient Schwann Cells Are More Susceptible to Radiation Injury than Normal Schwann Cells In Vitro.

Erin Cohen1, Stefanie Pena1, Christine Mei1, Olena Bracho1, Brian Marples2, Nagy Elsayyad2, Stefania Goncalves1, Michael Ivan3, Paula V Monje4,5, Xue-Zhong Liu1, Cristina Fernandez-Valle6, Fred Telischi1, Christine T Dinh1.   

Abstract

Objectives  Vestibular schwannomas (VS) are intracranial tumors, which are caused by NF2 gene mutations that lead to loss of merlin protein. A treatment for VS is stereotactic radiosurgery, a form of radiation. To better understand the radiobiology of VS and radiation toxicity to adjacent structures, our main objectives were (1) investigate effects of single fraction (SF) radiation on viability, cytotoxicity, and apoptosis in normal Schwann cells (SCs) and merlin-deficient Schwann cells (MD-SCs) in vitro, and (2) analyze expression of double strand DNA breaks (γ-H2AX) and DNA repair protein Rad51 following irradiation. Study Design  This is a basic science study. Setting  This study is conducted in a research laboratory. Participants  Patients did not participate in this study. Main Outcome Measures  In irradiated normal SCs and MD-SCs (0-18 Gy), we measured (1) viability, cytotoxicity, and apoptosis using cell-based assays, and (2) percentage of cells with γ-H2AX and Rad51 on immunofluorescence. Results  A high percentage of irradiated MD-SCs expressed γ-H2AX, which may explain the dose-dependent losses in viability in rodent and human cell lines. In comparison, the viabilities of normal SCs were only compromised at higher doses of radiation (>12 Gy, human SCs), which may be related to less Rad51 repair. There were no further reductions in viability in human MD-SCs beyond 9 Gy, suggesting that <9 Gy may be insufficient to initiate maximal tumor control. Conclusion  The MD-SCs are more susceptible to radiation than normal SCs, in part through differential expression of γ-H2AX and Rad51. Understanding the radiobiology of MD-SCs and normal SCs is important for optimizing radiation protocols to maximize tumor control while limiting radiation toxicity in VS patients. Thieme. All rights reserved.

Entities:  

Keywords:  DNA damage; DNA repair; Schwann cells; merlin-deficient; radiation; radiobiology; vestibular schwannoma

Year:  2021        PMID: 35769808      PMCID: PMC9236706          DOI: 10.1055/s-0040-1722283

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  45 in total

1.  Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139.

Authors:  E P Rogakou; W Nieves-Neira; C Boon; Y Pommier; W M Bonner
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

Review 2.  The molecular biology and novel treatments of vestibular schwannomas.

Authors:  Brendan Fong; Garni Barkhoudarian; Patrick Pezeshkian; Andrew T Parsa; Quinton Gopen; Isaac Yang
Journal:  J Neurosurg       Date:  2011-07-29       Impact factor: 5.115

3.  ATM phosphorylates histone H2AX in response to DNA double-strand breaks.

Authors:  S Burma; B P Chen; M Murphy; A Kurimasa; D J Chen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

Review 4.  The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.

Authors:  Michael R Lieber
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 5.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

6.  The changing face of acoustic neuroma management in the USA: analysis of the 1998 and 2008 patient surveys from the acoustic neuroma association.

Authors:  Jaymin Patel; Rohit Vasan; Harry van Loveren; Katheryne Downes; Siviero Agazzi
Journal:  Br J Neurosurg       Date:  2013-07-19       Impact factor: 1.596

7.  Prevalence of Sporadic Vestibular Schwannoma: Reconciling Temporal Bone, Radiologic, and Population-based Studies.

Authors:  John P Marinelli; Brandon R Grossardt; Christine M Lohse; Matthew L Carlson
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

Review 8.  Homologous recombination and its regulation.

Authors:  Lumir Krejci; Veronika Altmannova; Mario Spirek; Xiaolan Zhao
Journal:  Nucleic Acids Res       Date:  2012-03-30       Impact factor: 16.971

9.  Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.

Authors:  Alejandra M Petrilli; Jeanine Garcia; Marga Bott; Stephani Klingeman Plati; Christine T Dinh; Olena R Bracho; Denise Yan; Bing Zou; Rahul Mittal; Fred F Telischi; Xue-Zhong Liu; Long-Sheng Chang; D Bradley Welling; Alicja J Copik; Cristina Fernández-Valle
Journal:  Oncotarget       Date:  2017-05-09

Review 10.  Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy.

Authors:  Byeong Mo Kim; Yunkyung Hong; Seunghoon Lee; Pengda Liu; Ji Hong Lim; Yong Heon Lee; Tae Ho Lee; Kyu Tae Chang; Yonggeun Hong
Journal:  Int J Mol Sci       Date:  2015-11-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.